CNS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 380 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 101-125 of 380 matching filings.

Per page
25
Current page
5
424B5 File 333-279285

424B5

Filing date
27 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
26 Jun 2024
Reporting date
26 Jun 2024
Next action
Verify source filing
SC 13G File 005-93973

SC 13G filing

Filing date
25 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-39126

AMENDMENT TO CURRENT REPORT

Filing date
20 Jun 2024
Reporting date
14 Jun 2024
Next action
Verify source filing
424B5 File 333-279285

PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED MAY 17, 2024

Filing date
17 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-279285

EFFECT filing

Filing date
17 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39126

FORM 10-Q FOR 3/31/24

Filing date
15 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-279285

UPLOAD filing

Filing date
15 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-279285

FORM S-3

Filing date
09 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
15 Apr 2024
Reporting date
09 Apr 2024
Next action
Verify source filing
4

4 filing

Filing date
10 Apr 2024
Reporting date
08 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Apr 2024
Reporting date
08 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Apr 2024
Reporting date
08 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Apr 2024
Reporting date
08 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Apr 2024
Reporting date
08 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Apr 2024
Reporting date
08 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Apr 2024
Reporting date
08 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Apr 2024
Reporting date
08 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .